BIO vs A
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Apr 04, 2026
BIO
62.1
AI Score
VS
BIO Wins
A
60.2
AI Score
Investment Advisor Scores
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | BIO | A | Winner |
|---|---|---|---|
| Revenue | 1.89B | 1.80B | BIO |
| Net Income | 39.90M | 305.00M | A |
| Net Margin | 2.1% | 17.0% | A |
| Operating Income | 166.10M | 353.00M | A |
| ROE | 0.6% | 4.4% | A |
| ROA | 0.4% | 2.4% | A |
| Total Assets | 9.70B | 12.81B | A |
| Cash | 395.80M | 1.76B | A |
| Debt/Equity | 0.18 | 0.44 | BIO |
| Current Ratio | 5.44 | 2.07 | BIO |
| Free Cash Flow | 255.50M | 175.00M | BIO |
Frequently Asked Questions
Based on our detailed analysis, BIO is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.